Sale!

Whole Exome Sequencing WES Test

5,200 د.إ

-26%

Whole Exome Sequencing (WES) Test is an advanced genetic screening method offered by DNA Labs UAE, aimed at providing comprehensive insights into an individual’s genetic makeup. This test specifically focuses on the exome, which constitutes approximately 1% of the genome but contains the majority of known genetic variants associated with diseases. By examining the coding regions of genes where most genetic mutations occur, WES is highly effective in identifying genetic disorders, understanding rare diseases, and informing personalized medicine approaches.

The WES Test at DNA Labs UAE is priced at 5200 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then subjected to high-throughput sequencing to analyze the exome’s vast array of genetic information. This process enables the identification of both common and rare genetic variations that could be crucial in diagnosing genetic conditions, predicting disease risks, and tailoring medical treatments to the individual’s genetic profile.

DNA Labs UAE provides this service with a commitment to accuracy, confidentiality, and support through genetic counseling to help individuals understand their test results. The WES Test is a powerful tool in the field of genetic testing, offering insights that can significantly impact healthcare decisions and outcomes.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Whole Exome Sequencing WES Test Cost AED:5200.0

At DNA Labs UAE, we offer the Whole Exome Sequencing (WES) test at a cost of AED 5200.0. This test is designed to analyze the coding regions of a person’s DNA, known as the exome, and identify genetic variants associated with a person’s disease or condition.

Test Name: Whole Exome Sequencing WES Test

Components: Covers 23000 genes associated with known clinical phenotypes

Price: 5200.0 AED

Sample Condition: Blood

Report Delivery: 4 weeks

Method: NGS DNA Sequencing

Test Type: Genetics

Doctor: Physician

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information

WES provides the right balance of insights and price. Whole Genome Sequencing (WGS) takes too long, is often cost-prohibitive, and the data needed is usually in the exonic regions. Sanger sequencing and microarray are not cost-effective for large target regions. Targeted pre-defined panels often don’t contain all of the data needed for the project.

Test Details

Whole Exome Sequencing (WES) is a genetic test that analyzes the coding regions of a person’s DNA, known as the exome. The exome contains the genes that are responsible for producing proteins, which are the building blocks of the body. WES is a powerful tool for identifying genetic variants that may be associated with a person’s disease or condition.

During the WES test, a sample of a person’s DNA is extracted and purified. The exome is then captured using a technique called hybridization capture, which selectively binds and isolates the exome from the rest of the DNA. The captured exome is then sequenced using next-generation sequencing (NGS) technology, which reads the DNA sequence of the exome.

The resulting data is analyzed by bioinformaticians to identify genetic variants that may be associated with the person’s condition. These variants are compared to known databases of genetic variants to determine their significance. The results of the WES test can help diagnose genetic disorders, predict the risk of developing certain conditions, and guide treatment decisions.

Availability and Insurance Coverage

WES is a relatively new technology and is still being refined and improved. It is not yet available to everyone, and insurance coverage for the test may vary. However, as the technology continues to improve and become more widely available, WES has the potential to revolutionize the diagnosis and treatment of genetic diseases.

 

Test NameWhole Exome Sequencing WES Test
ComponentsCovers 23000 genes associated with known clinical phenotypes
Price5200.0 AED
Sample ConditionBlood
Report Delivery4 weeks
MethodNGS DNA Sequencing
Test typeGenetics
DoctorPhysician
Test Department:MOLECULAR DIAGNOSTICS
Pre Test InformationWES provides the right balance of insights and price Whole Genome Sequencing (WGS) takes too long, is often cost-prohibitive, and the data needed is usually in the exonic regions Sanger sequencing and microarray are not cost-effective for large target regions Targeted pre-defined panels often dont contain all of the data needed for the project
Test Details

Whole Exome Sequencing (WES) is a genetic test that analyzes the coding regions of a person’s DNA, known as the exome. The exome contains the genes that are responsible for producing proteins, which are the building blocks of the body. WES is a powerful tool for identifying genetic variants that may be associated with a person’s disease or condition.

 

During the WES test, a sample of a person’s DNA is extracted and purified. The exome is then captured using a technique called hybridization capture, which selectively binds and isolates the exome from the rest of the DNA. The captured exome is then sequenced using next-generation sequencing (NGS) technology, which reads the DNA sequence of the exome.

 

The resulting data is analyzed by bioinformaticians to identify genetic variants that may be associated with the person’s condition. These variants are compared to known databases of genetic variants to determine their significance. The results of the WES test can help diagnose genetic disorders, predict the risk of developing certain conditions, and guide treatment decisions.

 

WES is a relatively new technology and is still being refined and improved. It is not yet available to everyone, and insurance coverage for the test may vary. However, as the technology continues to improve and become more widely available, WES has the potential to revolutionize the diagnosis and treatment of genetic diseases.